Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ciltacabtagene Autoleucel (Carvykti) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Intravenous Immune Globulin (IVIG) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Carfilzomib (Kyprolis) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Canakinumab (Ilaris) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cabazitaxel (Jevtana) Cabazitaxel | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor Subcutaneous (Human) - Haegarda | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (recombinant) - Ruconest | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (Human) - Cinryze | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Browplasty | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Cerliponase Alfa(Brineura) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Lisocabtagene Maraleucel (Breyanzi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Brexucabtagene Autoleucel (Tecartus) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Breast Implant Removal | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Bortezomib (Velcade; Bortezomib, Boruzu) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Blinatumomab (Blincyto) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Zenocutuzumab-zbco (Bizengri) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Bevacizumab Products (Avastin; Mvasi ; Zirabev; Alymsys; Vegzelma, Avzivi, Jobevne) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Betibeglogene autotemcel (Zynteglo) (Intravenous) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Inotuzumab Ozogamicin (Besponsa) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Beremagene Geperpavec-svdt (Vyjuvek) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (Human) - Berinert | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Fidanacogene Elaparvovec-dzkt (Beqvez) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Brolucizumab-dbll (Beovu) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Benralizumab (Fasenra) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Bendamustine Products (Treanda, Belrapzo, Bendeka, Vivimusta, Bendamustine) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Belantamab Mafodotin-blmf (Blenrep) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Azacitidine (Vidaza) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Axicabtagene Ciloleucel (Yescarta) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Axatilimab-csfr (Niktimvo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Avalglucosidase Alfa-ngpt (Nexviazyme) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Obecabtagene Autoleucel (Aucatzyl) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Avacincaptad Pegol (Izervay) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Atidarsagene Autotemcel (Lenmeldy) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab and Hyaluronidase-tqjs (Tecentria Hybreza) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab (Tecentriq) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Calaspargase Pegol-mknl (Asparlas) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Asparaginase Erwinia chrysanthemi (recombinant)-rywn (Rylaze) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Nelarabine (Arranon) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Darbepoetin Alfa (Aranesp) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Aqueous Shunts and Stents for Glaucoma | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Nogapendekin Alfa-Inbakicept-pmln (Anktiva) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Anifrolumab-fnia (Saphnelo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Lifileucel (Amtagvi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Amivantamab-vmjw (Rybrevant) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Meniscal Allografts and Synthetic Meniscus Implants | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Allogeneic Processed Thymus Tissue-agdc (Rethymic) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Alglucosidase Alfa (Lumizyme) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Laronidase (Aldurazyme) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Aldesleukin IL‐2 (Proleukin) | Criteria changed |